Alpha DNA Investment Management’s DocuSign DOCU Stock Holding History

Alpha DNA Investment Management’s Portfolio DOCU Stock Details DOCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,698	Closed	-$1.05M	–	61
2024 Q4	$1.05M	Buy	+11,698	New	+$934K	0.4%	47
2024 Q1	–	Sell	-9,253	Closed	-$550K	–	211
2023 Q4	$550K	Sell	9,253 -3,224	-26%	-$148K	0.21%	96
2023 Q3	$524K	Sell	12,477 -2,596	-17%	-$127K	0.21%	130
2023 Q2	$770K	Buy	+15,073	New	+$798K	0.26%	111
2021 Q2	–	Sell	-6	Closed	-$1K	–	244
2021 Q1	$1K	Buy	+6	New	+$1.39K	﹤0.01%	617

Other funds holding DOCU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NMO

Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alpha DNA Investment Management's DOCU Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of DocuSign (DOCU) in Q1 2025, closing a stake of 11,698 shares — an estimated $1.05M sold.

Alpha DNA Investment Management first reported a position in DOCU in Q1 2021 and held it in 5 quarters. The position peaked at $1.05M in Q4 2024. 806 funds tracked by Wall St. Rank hold DOCU as of Q1 2025.

Alpha DNA Investment Management reported no remaining DocuSign position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 11,698 DocuSign shares in Q1 2025, an estimated $1.05M.
Alpha DNA Investment Management first reported a position in DocuSign in Q1 2021 and held it in 5 quarters.
Alpha DNA Investment Management's DocuSign position peaked at $1.05M in Q4 2024.
806 funds tracked by Wall St. Rank held DocuSign as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.